Susceptibility to hepatitis B infection, hepatitis B/HIV co-infections and hepatitis B immunity in HIV-positive patients starting HAART in Durban, South Africa
Background: HIV/HBV co-infection remains a global threat to HIV management despite the available effective hepatitis B vaccine and hepatitis B covering antiretroviral therapy. Many studies done in South Africa and internationally showed high prevalence of HIV/hepatitis B co-infection, which mandated...
Main Authors: | F. M. Chonco, S. Rangiah |
---|---|
Format: | Article |
Language: | English |
Published: |
AOSIS
2019-04-01
|
Series: | South African Family Practice |
Subjects: | |
Online Access: | https://safpj.co.za/index.php/safpj/article/view/5004 |
Similar Items
-
Isolated hepatitis B core antibody in HIV infected patients--can response to hepatitis B vaccine help to elucidate the cause?
by: Mohammad-Mahdi Majzoobi, et al.
Published: (2018-09-01) -
Seroprevalence of Hepatitis B, Hepatitis C and HIV in Police School Students
by: Fatih TEMOÇİN, et al.
Published: (2017-09-01) -
Hepatitis B oculta en pacientes VIH positivos de una institución de salud en Barranquilla Colombia. Occult Hepatitis B co-infection in health center patients with HIV in Barranquilla, Colombia.
by: Pedro Polo, et al.
Published: (2010-03-01) -
Seroprevalence of Hepatitis B, Hepatitis C and HIV in Intensive Care Unit Patients
by: Hakan Bayır, et al.
Published: (2015-08-01) -
Prevalence of hepatitis B and C in the sera of patients with HIV infection in São Paulo, Brazil
by: MENDES-CORRÊA Maria Cássia J., et al.
Published: (2000-01-01)